Cargando…

Nano Parthenolide Improves Intestinal Barrier Function of Sepsis by Inhibiting Apoptosis and ROS via 5-HTR2A

BACKGROUND: Intestinal barrier dysfunction is an important complication of sepsis, while the treatment is limited. Recently, parthenolide (PTL) has attracted much attention as a strategy of sepsis, but whether nano parthenolide (Nano PTL) is therapeutic in sepsis-induced intestinal barrier dysfuncti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Ning-Ke, She, Han, Tan, Lei, Zhou, Yuan-Qun, Tang, Chun-Qiong, Peng, Xiao-Yong, Ma, Chun-Hua, Li, Tao, Liu, Liang-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930579/ https://www.ncbi.nlm.nih.gov/pubmed/36816330 http://dx.doi.org/10.2147/IJN.S394544

Ejemplares similares

Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
por: Jorge, Joana, et al.
Publicado: (2023)

Parthenolide Attenuates Sepsis-Induced Acute Kidney Injury in Rats by Reducing Inflammation
por: Shou, Di-Wen, et al.
Publicado: (2023)

Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
por: Liu, Weifeng, et al.
Publicado: (2017)

Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
por: Yi, Juan, et al.
Publicado: (2022)

Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro
por: Liu, Jun-Wei, et al.
Publicado: (2010)

Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis
por: Cui, Meng, et al.
Publicado: (2022)

The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
por: An, Tao, et al.
Publicado: (2022)

Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia
por: Darwish, Noureldien H. E., et al.
Publicado: (2019)

Costunolide and Parthenolide Ameliorate MPP+ Induced Apoptosis in the Cellular Parkinson’s Disease Model
por: Arslan, Mehmet Enes, et al.
Publicado: (2023)

Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma
por: LI, YUAN, et al.
Publicado: (2012)

Omi/HtrA2 Protease Associated Cell Apoptosis Participates in Blood-Brain Barrier Dysfunction
por: Hu, Yueyu, et al.
Publicado: (2019)

PLK1 protects against sepsis-induced intestinal barrier dysfunction
por: Cao, Yingya, et al.
Publicado: (2018)

Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model
por: Kim, In Hee, et al.
Publicado: (2012)

Parthenolide Induces Apoptosis and Cell Cycle Arrest of Human 5637 Bladder Cancer Cells In Vitro
por: Cheng, Guang, et al.
Publicado: (2011)

Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway
por: Li, Hua, et al.
Publicado: (2018)

Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathways
por: Wan, Jun, et al.
Publicado: (2018)

Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases
por: Liu, Man, et al.
Publicado: (2018)

HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia
por: Grubor, Mirko, et al.
Publicado: (2020)

(E)-13-(4-Aminophenyl)parthenolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia
por: Li, Xingjian, et al.
Publicado: (2019)

The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm
por: Zhu, Sipin, et al.
Publicado: (2023)

The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice
por: Heimesaat, Markus M, et al.
Publicado: (2014)

Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways
por: Wan, Jun, et al.
Publicado: (2019)

Parthenolide Inhibits Cancer Stem-Like Side Population of Nasopharyngeal Carcinoma Cells via Suppression of the NF-κB/COX-2 Pathway
por: Liao, Kun, et al.
Publicado: (2015)

Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells
por: Zhao, Xiaofei, et al.
Publicado: (2014)

Cell death in amastigote forms of Leishmania amazonensis induced by parthenolide
por: Tiuman, Tatiana Shioji, et al.
Publicado: (2014)

Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
por: Bommagani, Shobanbabu, et al.
Publicado: (2015)

Parthenolide: a novel pharmacological approach to promote nerve regeneration
por: Diekmann, Heike, et al.
Publicado: (2016)

Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
por: Sztiller-Sikorska, Malgorzata, et al.
Publicado: (2020)

Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis
por: Zhang, Zhihui, et al.
Publicado: (2022)

Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
por: Carlisi, Daniela, et al.
Publicado: (2022)

Apoptosis-mediated cytotoxic effects of parthenolide and the new synthetic analog MZ-6 on two breast cancer cell lines
por: Wyrębska, Anna, et al.
Publicado: (2012)

Campylobacter jejuni enters gut epithelial cells and impairs intestinal barrier function through cleavage of occludin by serine protease HtrA
por: Harrer, Aileen, et al.
Publicado: (2019)

Evaluation of association of common variants in HTR1A and HTR5A with schizophrenia and executive function
por: Guan, Fanglin, et al.
Publicado: (2016)

Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease: Parthenolide covalently inhibits papain-like protease
por: Zou, Zhihui, et al.
Publicado: (2022)

Underestimated health risks: polystyrene micro- and nanoplastics jointly induce intestinal barrier dysfunction by ROS-mediated epithelial cell apoptosis
por: Liang, Boxuan, et al.
Publicado: (2021)

Crystal structure of 13-(E)-(2-aminobenzylidene)parthenolide
por: Bommagani, Shobanbabu, et al.
Publicado: (2018)

Covalent Modification of Human Serum Albumin by the Natural Sesquiterpene Lactone Parthenolide
por: Plöger, Michael, et al.
Publicado: (2015)

3114 Investigating the therapeutic potential of parthenolide in the treatment of hematopoietic neoplasms in dogs
por: Schlein, Lisa J, et al.
Publicado: (2019)

Decreasing microtubule detyrosination by parthenolide restores sodium current in mdx cardiomyocytes
por: Casini, S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1k7p7g1kp63s1tj1ofnni5ju4q